Therapy Areas: Infectious Diseases
Sanofi appoints new global head of Research & Development Pharma
23 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Monday the appointment of Paulo Fontoura, MD, PhD, FAAN, as executive vice president, global head of...
Lakewood-Amedex expands intellectual property portfolio with Australian Bisphosphocin patent
22 June 2026 - Biotechnology company Lakewood-Amedex Biotherapeutics Inc (NASDAQ: LABT) announced on Monday that it has secured a new composition of matter patent from IP Australia covering its Bispho...
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
22 June 2026 - Replicate Bioscience, a clinical-stage company developing novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic are...
Innoviva Specialty Therapeutics signs licensing agreement with Dr. Reddy's for XACDURO international expansion
16 June 2026 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc (Nasdaq:INVA) focused on innovative therapies in critical care and infectious disease, said on Tuesday that it has entered ...
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
12 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it is donating more than 2,000 vials of remdesivir to the Republic of Uganda to support response eff...
RedHill Biopharma advancing opaganib options for Ebola outbreak
4 June 2026 - Specialty biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) announced on Wednesday that it is actively discussing potential collaborations for advancement of its investigatio...